
Paul Biondi
@paulbiondi9
Pioneering medicines to benefit more patients, sooner. President @PioneeringMeds & Executive Partner @FlagshipPioneer avid sailor & hiking enthusiast
ID: 1430904721359785991
26-08-2021 14:50:46
72 Tweet
240 Followers
23 Following

We’re looking forward to working with Charles River Labs and Valo Health to deploy their AI-powered Logica™ platform toward our focus on creating and delivering novel medicines. More here: flagshippioneering.com/press/charles-…

On International Women's Day, I want to celebrate and share my thanks for the incredible female colleagues that inspire me each day at Pioneering Medicines #IWD #IWD2023 Flagship Pioneering

Thanks to The Pharma Letter for a great conversation about our work at Pioneering Medicines to create new therapeutics for patients through innovative partnerships and by drawing on Flagship Pioneering’s unique ecosystem of first-in-category bioplatform companies.

Thank you Bob Coughlin for joining our Pioneering Medicines retreat to share your family’s journey with #cysticfibrosis. Your commitment to the CF community inspired us and reinforced why we’re driven to discover and develop novel therapeutics that make a difference for patients.



Flagship and the Pioneering Medicines team look forward to working with Pfizer Inc.'s R&D leadership to create an expansive program of innovative medicines. I’m particularly excited about our focus on unmet need and exploring disease areas where we can make a difference for patients.

Great to connect with Brad Loncar and share more about Flagship’s new partnership with Pfizer Inc. to bring new medicines to patients. More from our conversation here: biotechtv.com/post/paul-bion…


Hear from CTO of #Flagshipfounded Seres Therapeutics David Ege on how the company is pioneering microbiome therapeutics and what makes the work that they do exciting and unique.🥼

It’s terrific to welcome Amanda Kay into her new role as Flagship’s Chief Business Development Officer. I’m excited to work with her to help potential partners understand the opportunities to work with us at Flagship and Pioneering Medicines and bring novel treatments to patients.

It was great to chat with @PhamaExec about how we create companies at Flagship Pioneering, our partnerships with biopharma, and more about Pioneering Medicines.

I’m looking forward to joining Novo Nordisk's Head of the Bio Innovation Hub Uli Stilz at Reuters Events Pharma & Patient USA on Nov 17 to talk about Flagship’s partnership with Novo Nordisk to create novel medicines to address unmet need for patients.

It’s incredibly exciting to be initiating the first two research collaborations from our partnership with Novo Nordisk with Flagship-founded bioplatforms Omega Therapeutics and Cellarity.

Looking forward to these two great conversations at JPM with Pfizer Inc.'s Charlotte Allerton (Charlotte Allerton) and with Omega Therapeutics's Mahesh Karande and Uli Stilz of Novo Nordisk on the power and potential of partnerships across biopharma to bring new therapeutics to patients.

Looking forward to this conversation today with Charlotte Allerton about innovative partnerships in biopharma including Flagship's strategic alliance with Pfizer Inc..

Thank you, Charlotte Allerton, for joining me at our Flagship Studio and sharing your insights on partnering in biopharma. Looking forward to what our teams will accomplish together.


We're excited to share our third research collaboration as part of Flagship Pioneering's strategic partnership with Novo Nordisk. We look forward to working with #FlagshipFounded Metaphore Biotechnologies and our partners at Novo to develop novel therapeutics for obesity management.⬇️⬇️

Our research collaboration with #FlagshipFounded Metaphore Biotechnologies and Novo Nordisk will focus on developing next-gen therapeutics to address unmet need in obesity management. Read more about our third research collaboration under Flagship's strategic partnership with Novo Nordisk ⬇️

Flagship and #FlagshipFounded ProFoundTx announce a collaboration to identify novel first-in-class therapies for the treatment of obesity, the first exploration agreement under Flagship's Pioneering Medicines strategic partnership with Pfizer Inc.. Read the full announcement:

